ArticleEuropean journal of medical research2025
Diagnostic value of different skeleton muscles in elderly COPD patients with sarcopenia.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Retrospective pilot study on the correlation between masseter muscle volume and myocardial function parameters.Oral radiology · 2026Article
- Screening Utility of Lower Limb Muscle Ultrasound for Sarcopenia in COPD Patients.International journal of chronic obstructive pulmonary disease · 2026Article
- Analysis of risk factors for calf muscular vein thrombosis in elderly patients with acute exacerbation of chronic obstructive pulmonary disease.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThe purpose of this study was to explore the value of different skeletal muscles in assessing muscle mass in elderly chronic obstructive pulmonary disease (COPD) patients with sarcopenia. PATIENTS AND
methodsA cross-sectional analysis was conducted on a sample of elderly COPD patients with and without sarcopenia. Muscle mass measurements, including body mass index (BMI), weight, skeletal muscle index (SMI), 6-m walk test (6MWT), five-repetition sit-to-stand test (5STS), grip strength, calf circumference (CC), rectus abdominis thickness (RAT), rectus femoris cross-sectional area (RF-CSA), quadriceps femoris muscle thickness (QFMT), L1 muscle cross-sectional area (L1M CSA), and pectoralis muscle cross-sectional area (PM CSA). Statistical analyses were performed to assess the correlations between these muscle measurements and muscle mass, as well as the diagnostic value of low muscle mass (LMM) in elderly COPD patients.
resultsThe results showed that there were significant differences in BMI, weight, SMI, gait speed, 5STS, grip strength, and CC between the LMM group and the normal muscle mass (NMM) group (P < 0.05). The ultrasound measurements showed that RAT, RF-CSA, and QFMT were significantly lower in the LMM group compared to the NMM group (P < 0.05). Similarly, the comparison of CT measurement parameters revealed that in the LMM group, both L1M CSA and PM CSA were significantly lower than those in the NMM group (P < 0.05). Correlation analysis revealed strong positive correlations between SMI and CC, L1M CSA, and RAT in the LMM group (p < 0.01), but no significant correlations were found with certain parameters. Receiver-operating characteristic curve analysis showed that the AUC values of PM CSA, QFMT, L1M CSA, RF-CSA and RAT in the diagnosis of LMM in elderly male COPD patients were 0.850, 0.830, 0.802, 0.722 and 0.684.
conclusionL1M CSA, RAT, RF-CSA, PM CSA, QFMT, and CC are positively correlated with muscle mass in elderly COPD patients with sarcopenia, and CC is a good screening index for predicting muscle mass. PM CSA and QFMT may be good indicators for the diagnosis of LMM in elderly male COPD patients with sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.